Related Experiment Videos
VEGF-FLT1 receptor system: a new ligand-receptor system involved in normal and tumor angiogenesis
1Laboratory of Molecular Oncology U. 119 Inserm, Marseille, France.
Japanese Journal of Cancer Research : Gann
|July 1, 1995
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Publisher Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations.
Nature structural & molecular biology·2020
Author Correction: SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations.
Nature structural & molecular biology·2020
SLX4 interacts with RTEL1 to prevent transcription-mediated DNA replication perturbations.
Nature structural & molecular biology·2020
Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique·2020
The Genomic Grade Index predicts postoperative clinical outcome in patients with soft-tissue sarcoma.
Annals of oncology : official journal of the European Society for Medical Oncology·2017
Beta-hydroxyisovalerylshikonin is a novel and potent inhibitor of protein tyrosine kinases.
Japanese journal of cancer research : Gann·2003
Calponin h1 suppresses tumor growth of Src-induced transformed 3Y1 cells in association with a decrease in angiogenesis.
Japanese journal of cancer research : Gann·2003
Dendritic cell appearance and differentiation during early and late stages of rat stomach carcinogenesis.
Japanese journal of cancer research : Gann·2003
Natural antigenic peptides from squamous cell carcinoma recognized by autologous HLA-DR8-restricted CD4+ T cells.
Japanese journal of cancer research : Gann·2003
Molecular cytogenetic characterization of drug-resistant leukemia cell lines by comparative genomic hybridization and fluorescence in situ hybridization.
Japanese journal of cancer research : Gann·2003
Integrating a Tumor Size-Overall Survival Model Into a Spatial Quantitative Systems Pharmacology Framework for Antibody-Drug Conjugates in Non-Small Cell Lung Cancer.
CPT: pharmacometrics & systems pharmacology·2026
The Future of all-Comers Trials in the Era of Precision Oncology.
Clinical pharmacology and therapeutics·2026
MyoD and Myogenin regulatory cascade is targeted by tumor signals to repress myogenesis in cancer cachexia.
The Biochemical journal·2026
Beyond the cerebrospinal fluid: Preclinical and clinical evidence on central nervous system penetration and functional activity of oral rapamycin (sirolimus).
Journal of Alzheimer's disease : JAD·2026
Conferone: Sources, Anticancer Mechanisms, and Potential in Overcoming Chemoresistance - A Comprehensive Review.
Current pharmaceutical design·2026